Voltaren Schmerzgel forte from Novartis AG - 12-hour relief for stressed joints

Reviewed: ad hoc news Classics & Longseller desk. Edited and checked on 2026-06-28, 14:03. Details in the imprint.

Voltaren Schmerzgel forte lands in the palm as a cool, slightly medicinal-smelling stripe of gel that you massage into a tight lower back until the skin feels faintly tacky and pleasantly cooled. The gel is a long-running pain relief classic in many European bathrooms.

What Voltaren forte does

Voltaren Schmerzgel forte is a topical pain relief gel with 23.2 mg/g diclofenac, designed to ease joint, muscle and back pain directly at the affected area. In typical pharmacy listings, it is sold in 100 g, 150 g and 180 g tubes for over-the-counter use.

The forte formulation is marketed as providing up to 12 hours of pain relief, so users typically apply it only twice a day instead of every few hours. That twice-daily rhythm is meant to replace a standard day’s dose of over-the-counter pain tablets in many everyday situations.

How it is used day to day

In everyday practice, people squeeze a ribbon of Voltaren Schmerzgel forte onto a fingertip or palm and spread it over the painful area, for example along the spine or around a swollen knee. Pharmacists advise against using it longer than three to four days without medical review.

The gel is geared towards adults with movement-related pain from sprains, strains or osteoarthritis, not for children or people with known diclofenac intolerance. Visible skin irritation, persistent pain or swelling remain clear signals to stop self-treatment and consult a physician.

Where it stands in the market

Voltaren has been a household name for topical diclofenac in Europe for decades, and the forte variant is often highlighted by pharmacies as their higher-strength gel option. Retail sites list Haleon as the local German marketer, reflecting how consumer rights to the brand have shifted over time.

Behind the brand, Novartis used to sit in a broader consumer health joint venture before focusing more sharply on prescription medicines. Today, the Voltaren name still carries weight with users who associate the white-and-orange tubes with reliable, familiar pain relief rather than novelty.

What users like and dislike

Many users appreciate the cool sensation and the fact that Voltaren Schmerzgel forte does not smell strongly once rubbed in, which makes it discreet under clothes or in an open-plan office. The twice-daily schedule also fits neatly with morning and evening routines.

On the downside, the gel can leave a slight film that feels sticky if too much is applied at once, and some users complain about having to wait for it to dry before dressing. Cost can also add up when larger tubes are used regularly, even in over-the-counter channels.

Safety and limits of self-medication

Diclofenac, even in topical form, is not a harmless cosmetic. Pharmacies in Germany point out that higher oral doses require a prescription and that self-treatment with over-the-counter strengths should be limited to a few days without doctor supervision.

Those with heart disease, kidney problems or a history of stomach ulcers are generally advised to be cautious with systemic anti-inflammatory medicines, and to consider local options like gels only after discussing their specific situation with a healthcare professional.

Portfolio and share reference

Voltaren Schmerzgel forte sits alongside high-margin prescription drugs in Novartis’s broader mix, even if consumer pain relief is no longer the strategic core. Basel-based CEO Vasant Narasimhan has repeatedly stressed a focus on innovative medicines while pruning non-core assets from the portfolio.

Novartis shares (ISIN CH0012005267) trade on SIX Swiss Exchange under the symbol NOVN; recent quote services show the stock in the mid-130 Swiss franc area, reflecting the company’s status as a large-cap Swiss healthcare name.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.